학술논문
INTERIM RESULTS OF PHASE 1/2A CLINICAL STUDY OF AR-501, AN INVESTIGATIONAL INHALED FORMULATION OF GALLIUM CITRATE BEING EVALUATED AS AN ANTIBACTERIAL IN CYSTIC FIBROSIS PATIENTS
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
10990496